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Introduction
Still’s disease or systemic juvenile idiopathic arthritis (sJIA)
is a severe inflammatory disease of childhood character-
ized by periods of daily spiking fever, evanescent skin rash,
severe arthritis, serositis, lymphoid hyperplasia, and, in up
to half of cases, macrophage activation syndrome.
Although thought to have a genetic component, the causes
of sJIA are unknown.
Objectives
To identify genetic factors that contribute to sJIA
susceptibility.
Methods
We generated single nucleotide polymorphism (SNP) gen-
otypes from the genomic DNA of 988 children with sJIA
and 514 healthy control subjects. These data were com-
bined with SNP genotypes in silico from 7370 additional
healthy control subjects. After dividing the dataset into 9
strata by country of origin, we excluded samples and mar-
kers that did not meet our strict quality requirements. We
performed haplotype phasing with ShapeIT, SNP imputa-
tion with IMPUTE2, and association testing with
SNPTEST independently in each stratum. The results of
association testing were subjected to fixed- and random-
effects meta-analyses with GWAMA. A second round of
more intensive “deep imputation” was performed in each
region with pmeta<1E-7. Using the directly genotyped SNP
data, we used imputation to deduce classical HLA types in
each stratum. Significant associations were further evalu-
ated with multivariate logistic regression using SNPTEST
and SNP & Variation Suite 7.
Results
Using the above method, we ultimately tested a panel of
over 1.6M SNPs for association with sJIA. Using meta-
analysis of SNP association data from 9 strata, we identi-
fied 2 sJIA-associated regions that exceeded the stringent
threshold for genome wide significance (pmeta<5E-8). The
strongest association was located in the major histocom-
patibility complex locus, with one SNP nearest to HLA-
DRB1 (rs112638393: pmeta=1.6E-10, OR 1.5 [1.3, 1.7])
and a second located nearest to BTNL2 (rs115945836:
pmeta=2.4E-10, OR 2.8 [2.0, 3.9]). Conditioning on the
effect of rs112638393 accounted for the majority of the
effect around HLA-DRB1, while revealing a significant,
independent association signal spanning BTNL2 and
HLA-DRA. Additionally, meta-analysis of the imputed
HLA type associations from 8 strata revealed a strong
association between HLA-DRB1*1101 and sJIA (pme-
ta=1.2E-8, OR 2.1 [1.6, 2.7]). The second strongest regio-
nal association, which also exceeded genome wide
significance, was located on Chr 1 nearest to LOC284661
(rs16838915: pmeta=5.4E-9, OR 2.0 [1.6, 2.5]). Logistic
regression analysis demonstrated no residual association
signal in this region after conditioning on rs16838915. In
total, our study identified 11 loci that were suggestive of
association with sJIA (p<5E-5).
Conclusion
We have per-
formed a genome-wide association study of a large col-
lection of sJIA patients. We have identified 2 sJIA
susceptibility loci, HLA-DRB1 and LOC284661, both of
which have large effect sizes. The association of HLA-
DRB1*1101 with sJIA suggests that antigen presentation
and the adaptive immune system are involved in sJIA, an
idea that would be further supported by involvement of
either HLA-DRA or BTNL2. The specific roles of each of
1Translational Genetics and Genomics Unit, NIAMS, Bethesda, MD, USA
Full list of author information is available at the end of the article
Ombrello et al. Pediatric Rheumatology 2013, 11(Suppl 1):A91
http://www.ped-rheum.com/content/11/S1/A91
© 2013 Ombrello et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.





1Translational Genetics and Genomics Unit, NIAMS, Bethesda, MD, USA.
2Inflammatory Disease Section, NHGRI, Bethesda, MD, USA. 3Applied
Statistical Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
4Arthritis Research UK Epidemiology Unit, University of Manchester,
Manchester, UK. 5Center of Paediatric and Adolescent Rheumatology,
University College London, London, UK.
Published: 8 November 2013
doi:10.1186/1546-0096-11-S1-A91
Cite this article as: Ombrello et al.: PW01-038 – Genomewide
association study of Still’s disease. Pediatric Rheumatology 2013
11(Suppl 1):A91.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ombrello et al. Pediatric Rheumatology 2013, 11(Suppl 1):A91
http://www.ped-rheum.com/content/11/S1/A91
Page 2 of 2
